How beneficial is radioiodine therapy for treating distant metastases from thyroid carcinoma?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 11, 2006, Pages 610-611

  Mazzaferri, Ernest L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE;

CANCER LOCALIZATION; CANCER REGRESSION; CANCER SURVIVAL; CELL DIFFERENTIATION; HUMAN; METASTASIS; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; THYROID CARCINOMA; X RAY ANALYSIS;

EID: 33750618104     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0317     Document Type: Note

References (5)

1. Hundahl SA et al. (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83: 2638-2648
2. Kitamura Y et al. (1999) Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 84: 4043-4049
3. Dinneen SF et al. (1995) Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80: 2041-2045
4. Hindié E et al. (2003) Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 30: 974-981
5. Bal CS et al. (2004) Is chest X-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid 14: 217-225